Nevertheless, prospective studies on the long-term efficacy and safety of intravenous iron are warranted. Moreover, recommendations for the optimal formulation, doses and treatment schemes of iron ...
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark COPENHAGEN, DENMARK—21 January 2025 — CSL Behring Denmark today announced that the first ...
For the treatment of hypertension, the initial dose of nitroglycerin is 5 µg/min by i.v. infusion. The dose may be increased in increments of 5 µg/min every 3–5 minutes to a maximum rate of 20 ...